{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:46:11Z","timestamp":1773369971583,"version":"3.50.1"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Evidence of cost-effectiveness is needed to demonstrate the value of smoking cessation behavioral interventions.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the cost-effectiveness of motivation and problem-solving (MAPS) against standard treatment (ST) for smoking cessation among patients with a history of cervical intraepithelial neoplasia or cervical cancer.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this economic evaluation, a cost-effectiveness analysis was conducted from the perspective of cancer centers using data collected in a randomized clinical trial conducted between February 2017 and January 2020 with follow-up until August 2021 that compared MAPS with ST. MAPS is a behavioral intervention that emphasizes smoking cessation and relapse prevention while addressing life events, stressors, and other individual concerns. The trial included up to 6 counseling sessions of MAPS delivered over 12 months. Data were analyzed from January 2024 to December 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Inclusion in a smoking cessation randomized clinical trial that compared MAPS with ST.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Deterministic and probabilistic cost-effectiveness analyses were conducted and findings were reported as incremental cost-effectiveness ratio and cost-effectiveness acceptability curve, respectively, for 7-day point prevalence abstinence at months 12 and 18.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The analysis included 194 participants. Study participants had a mean (SD) age of 47.8 (10.8) years, had a mean (SD) smoking history of 29.1 (12.1) years, and smoked a mean (SD) of 15.5 (8.7) cigarettes per day. Mean costs were $522.74 (95% CI, $500.19 to $545.29) and $389.26 (95% CI, $362.67 to $415.84) per participant for MAPS (98 participants) and ST (96 participants), respectively. At month 12, abstinence rates were 26.5% and 12.5% for MAPS and ST, respectively. The deterministic analysis found that the incremental cost for MAPS vs ST was $921 per quit at month 12 and $7458 per quit at month 18. The probabilistic analysis found that at the societal willingness to pay of $10\u202f000 per quit, the probability that MAPS is cost-effective at month 12 was nearly 100% but reduced to 52% at month 18. Subgroup analysis found a lower incremental cost-effectiveness ratio when comparing the high MAPS engagement subgroup with the ST group. The cost-effectiveness of MAPS (vs ST) was sustained at month 18 among the high MAPS engagement subgroup despite a decline in 7-day abstinence.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cost-effectiveness analysis, there was robust evidence supporting the cost-effectiveness of MAPS (vs ST) at month 12 and moderate evidence at month 18 in terms of incremental cost per quit. The attenuation of intervention outcome over time was more pronounced among participants with less than 4 sessions of MAPS.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.1543","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:30:35Z","timestamp":1773329435000},"page":"e261543","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Xiaoyu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damon J.","family":"Vidrine","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida"},{"name":"Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven K.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa"},{"name":"Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida"},{"name":"Department of Psychology, University of South Florida, Tampa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Wetter","sequence":"additional","affiliation":[{"name":"University of Utah and Huntsman Cancer Institute, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer I.","family":"Vidrine","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida"},{"name":"Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa"},{"name":"Department of Psychology, University of South Florida, Tampa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Chen Tina","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles"},{"name":"Jonsson Comprehensive Cancer Center, Program in Cancer Health Economics Research, University of California Los Angeles"},{"name":"Department of Radiation Oncology, School of Medicine, University of California Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"7","key":"zoi260079r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.9072","article-title":"Smoking behaviors in survivors of smoking-related and non-smoking-related cancers.","volume":"3","author":"Gritz","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi260079r9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ijc.27617","article-title":"Smoking at diagnosis and survival in cancer patients.","volume":"132","author":"Warren","year":"2013","journal-title":"Int J Cancer"},{"issue":"2","key":"zoi260079r10","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1188\/11.ONF.E107-E117","article-title":"Quality of life in cervical cancer survivors: a review of the literature and directions for future research.","volume":"38","author":"Zeng","year":"2011","journal-title":"Oncol Nurs Forum"},{"issue":"7","key":"zoi260079r11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10552-012-9957-2","article-title":"Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992-2008.","volume":"23","author":"Underwood","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"3","key":"zoi260079r12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/COC.0000000000000268","article-title":"Smoking decreases survival in locally advanced cervical cancer treated with radiation.","volume":"41","author":"Mayadev","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"zoi260079r13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.5993\/AJHB.43.3.14","article-title":"Smoking cessation treatment needs of low SES cervical cancer survivors.","volume":"43","author":"Hoover","year":"2019","journal-title":"Am J Health Behav"},{"issue":"12","key":"zoi260079r14","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/ntr\/ntz007","article-title":"Likelihood of smoking among cancer survivors: an updated health information national trends survey analysis.","volume":"21","author":"Swoboda","year":"2019","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"zoi260079r15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1037\/adb0000692","article-title":"A descriptive study of cervical cancer survivors\u2019 persistent smoking behavior and perceived barriers to quitting.","volume":"36","author":"Borger","year":"2022","journal-title":"Psychol Addict Behav"},{"issue":"15","key":"zoi260079r16","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1200\/JCO.22.01228","article-title":"Efficacy of a smoking cessation intervention for survivors of cervical intraepithelial neoplasia or cervical cancer: a randomized controlled trial.","volume":"41","author":"Vidrine","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"zoi260079r17","doi-asserted-by":"publisher","DOI":"10.2196\/34502","article-title":"Evaluation of the efficacy of a smoking cessation intervention for cervical cancer survivors and women with high-grade cervical dysplasia: protocol for a randomized controlled trial.","volume":"10","author":"Jones","year":"2021","journal-title":"JMIR Res Protoc"},{"issue":"1","key":"zoi260079r18","doi-asserted-by":"publisher","DOI":"10.1177\/23814683211061097","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.","volume":"7","author":"Husereau","year":"2022","journal-title":"MDM Policy Pract"},{"issue":"1","key":"zoi260079r21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amepre.2023.01.006","article-title":"Cost-effectiveness of smoking cessation approaches in emergency departments.","volume":"65","author":"Miller","year":"2023","journal-title":"Am J Prev Med"},{"key":"zoi260079r22","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2006.019794","author":"Hollis","year":"2007","journal-title":"Tob Control"},{"key":"zoi260079r23","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2007.019943","author":"Fellows","year":"2007","journal-title":"Tob Control"},{"issue":"1","key":"zoi260079r24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amepre.2006.08.031","article-title":"Organization, financing, promotion, and cost of U.S. quitlines, 2004.","volume":"32","author":"Keller","year":"2007","journal-title":"Am J Prev Med"},{"issue":"7","key":"zoi260079r26","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ntr\/ntz110","article-title":"Defining and measuring abstinence in clinical trials of smoking cessation interventions: an updated review.","volume":"22","author":"Piper","year":"2020","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"zoi260079r28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s13142-010-0009-8","article-title":"Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation.","volume":"1","author":"Javitz","year":"2011","journal-title":"Transl Behav Med"},{"issue":"2","key":"zoi260079r29","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making"},{"issue":"7","key":"zoi260079r30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V","article-title":"Definition, interpretation and calculation of cost-effectiveness acceptability curves.","volume":"9","author":"L\u00f6thgren","year":"2000","journal-title":"Health Econ"},{"issue":"6","key":"zoi260079r31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.16362","article-title":"Cost-effectiveness of implementing smoking cessation interventions for patients with cancer.","volume":"5","author":"Levy","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260079r32","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1186\/s12889-023-16189-3","article-title":"Enhancing long-term smoking abstinence among individuals with a history of cervical intraepithelial neoplasia or cervical cancer (Project ACCESS): protocol for a randomized clinical trial.","volume":"23","author":"Vidrine","year":"2023","journal-title":"BMC Public Health"},{"issue":"1","key":"zoi260079r33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/ntr\/nts083","article-title":"Tobacco use treatment at the U.S. National Cancer Institute\u2019s designated cancer centers.","volume":"15","author":"Goldstein","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"5","key":"zoi260079r34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/JTO.0b013e318288dc96","article-title":"Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients.","volume":"8","author":"Warren","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"5","key":"zoi260079r35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JOP.2013.001025","article-title":"Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members.","volume":"9","author":"Warren","year":"2013","journal-title":"J Oncol Pract"},{"issue":"3","key":"zoi260079r36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1634\/theoncologist.2011-0350","article-title":"Smoking cessation counseling beliefs and behaviors of outpatient oncology providers.","volume":"17","author":"Weaver","year":"2012","journal-title":"Oncologist"},{"issue":"2","key":"zoi260079r37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1200\/OP.23.00393","article-title":"Current practices, perceived barriers, and promising implementation strategies for improving quality of smoking cessation support in accredited cancer programs of the American College of Surgeons.","volume":"20","author":"Ostroff","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"zoi260079r3","volume-title":"How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services","year":"2010"},{"key":"zoi260079r27","volume-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"key":"zoi260079r1","unstructured":"U.S. Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General. 2014. Accessed January 30, 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK179276\/"},{"key":"zoi260079r2","unstructured":"U.S. National Cancer Institute. Treating smoking in cancer patients: an essential component of cancer care. 2025. Accessed April 22, 2025. https:\/\/cancercontrol.cancer.gov\/brp\/tcrb\/monographs\/monograph-23"},{"key":"zoi260079r4","unstructured":"U.S. Centers for Disease Control and Prevention. Tobacco product use among adults-United States, 2022. Accessed February 21, 2025. https:\/\/www.cdc.gov\/tobacco\/media\/pdfs\/2024\/09\/cdc-osh-ncis-data-report-508.pdf#page=10.11"},{"key":"zoi260079r5","unstructured":"American Cancer Society. Cancer facts and figures 2025. 2025. Accessed January 30, 2026. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2025\/2025-cancer-facts-and-figures-acs.pdf"},{"key":"zoi260079r6","unstructured":"American Cancer Society. Cancer treatment and survivorship facts and figures 2022-2024. 2022. Accessed January 30, 2026. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/cancer-treatment-and-survivorship-facts-and-figures\/2022-cancer-treatment-and-survivorship-fandf-acs.pdf"},{"key":"zoi260079r7","unstructured":"U.S. National Cancer Institute. Cancer trends progress report. 2024. Accessed January 30, 2026. https:\/\/progressreport.cancer.gov\/"},{"key":"zoi260079r19","unstructured":"U.S. Bureau of Labor Statistics. Occupational employment and wages, May 2024. July 27, 2025. Updated May 2024. Accessed July 27, 2025. https:\/\/www.bls.gov\/oes\/tables.htm"},{"key":"zoi260079r20","unstructured":"U.S. Bureau of Labor Statistics. Employer costs for employee compensation for private industry workers by occupational and industry group, March 2024. August 5, 2024. Updated June 18, 2024. Accessed August 5, 2024. https:\/\/www.bls.gov\/news.release\/ecec.t04.htm"},{"key":"zoi260079r25","unstructured":"CommercialCafe. Office spaces for rent in Oklahoma City, OK. July 27, 2025. Accessed July 27, 2025. https:\/\/www.commercialcafe.com\/office-market-trends\/us\/ok\/oklahoma-city\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846288\/liu_2026_oi_260079_1772728688.03121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:30:50Z","timestamp":1773329450000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.1543","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}